Shannon Morey Kinney

Shannon Morey Kinney is a Professor of Pharmacology at Western New England University in the Department of Pharmaceutical & Admv Sciences. She serves as the MS in Pharmacogenomics Program Coordinator and contributes to interdisciplinary research in gene regulation via DNA methylation and hydroxymethylation in cancer, particularly prostate cancer, alongside educational research in pharmacogenomics curriculum design.

• B.S. in Environmental and Forest Biology, SUNY College of Environmental Science and Forestry
• Ph.D. in Pharmacology and Therapeutics, SUNY at Buffalo - Roswell Park Cancer Institute
• Post-doctoral fellowship in RNA Biology Division, New England Biolabs, Inc.

Her research focuses on epigenetic mechanisms in cancer progression, including DNA methylation, hydroxymethylation, and histone acetylation, alongside educational research on pharmacogenomics teaching methods. Recent publications highlight her dual expertise in cancer epigenetics and pharmacy education pedagogy, including studies on student engagement and clinical integration of pharmacogenomics.

Notable scholarly works include investigations into TET enzymes in cancer, histone acetylation in allergic responses, and longitudinal educational strategies in pharmacy training. Her publications span journals such as Journal of Biological Chemistry, Currents in Pharmacy Teaching and Learning, and Frontiers in Immunology.

• Pharmacology of immunotherapeutic drugs (2020)
• Epigenetic regulation via altered histone acetylation (2018)
• 5-Hydroxymethylcytosine dynamics in mammalian genomes (2011)